Shareholders to Vote on Massive Dilution Amidst 'Going Concern' Warning

summarizeSummary

INVO Fertility, Inc. is asking shareholders to approve several highly dilutive measures, including a massive increase in authorized shares and a large future equity financing, as it faces severe financial distress and a 'going concern' warning.

check_boxKey Events

• Proposed Increase in Authorized Shares

  Shareholders will vote on increasing the authorized common stock from 50,000,000 to 250,000,000 shares. This represents a potential dilution of approximately 13,897% relative to the current 1,786,035 outstanding shares, providing vast headroom for future equity raises.

• Approval for Future Equity Financing

  The company seeks approval to issue up to 20,000,000 shares in a future equity financing, potentially raising up to $50,000,000. This alone represents approximately 1,120% of the current outstanding shares and is nearly 19 times the company's current market capitalization, indicating a desperate need for capital at potentially deep discounts.

• Inducement Warrant Issuance Approval

  Shareholders are asked to approve the issuance of up to 1,893,492 shares upon the exercise of inducement warrants at an exercise price of $7.95 per share. This represents approximately 106% of the current outstanding shares.

• Expanded Stock Incentive Plan

  The company proposes to increase the shares available for its 2019 Stock Incentive Plan to a total of 1,000,000 shares, equivalent to approximately 56% of the current outstanding shares, further contributing to potential dilution.

auto_awesomeAnalysis

INVO Fertility, Inc., a company recently disclosing 'substantial doubt about its ability to continue as a going concern' and undergoing financial restatements, is seeking shareholder approval for multiple highly dilutive proposals. These include a five-fold increase in authorized common stock to 250 million shares, approval for issuing nearly 1.9 million shares from inducement warrants, expanding its stock incentive plan by 1 million shares, and authorizing a future equity financing of up to 20 million shares, potentially raising up to $50 million. The cumulative potential dilution from these proposals is extreme, indicating a critical need for capital that will significantly impact existing shareholder value and ownership percentages.